The first GLP-1 drug, Exenatide (brand name Byetta), was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes
"We're also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications.'" Him & Hers' weight loss offerings have been a massive hit with investors
Shop MC UK's go-to expert-approved supplements here: Magnesium is having a moment, and with good reason: most of us in the UK aren't getting enough of this essential mineral
Rotating injection sites is recommended to reduce local irritation and avoid repeatedly injecting the same area of tissue
It might look concerning, but its ultimately harmless, and these bruises typically only last a few days at most
Why Two Pathways Beat One The body protects its weight set point with redundancy